NCOIL Pushes Back Against Trump’s AI Regulation Order: What It Means for Insurance Professionals

Ai regulation governance image

A sharp political and regulatory conflict has erupted as the National Council of Insurance Legislators (NCOIL) publicly challenges President Donald Trump’s executive order on artificial intelligence. The directive seeks to reduce state involvement in AI oversight—an approach NCOIL argues threatens the very structure of U.S. insurance governance.

In a strongly worded December 15 statement, NCOIL expressed that it was “greatly disturbed” by the attempt to centralize AI authority in Washington, suggesting it could weaken consumer protection and restrict states’ ability to maintain regulatory balance. Their stance is unmistakable: states must preserve the right to craft their own policy, especially in a period of political gridlock.

Why This Matters: The Longstanding State vs. Federal Tug‑of‑War

Insurance regulation has traditionally belonged to the states. Moving that authority to the federal level could disrupt markets, slow innovation, and complicate compliance. This isn’t the first time such concerns have surfaced—a decade‑long moratorium on state AI regulation was previously shot down by federal lawmakers following pushback from NCOIL and major insurance trade groups warning the moratorium would “wrongly curtail” state authority.

“This moment is precisely the kind of opportunity in which the states should continue serving as the laboratories of democracy,” NCOIL declared—adding that Trump’s order will likely face significant legal challenges.

What the Executive Order Actually Says

The administration argues that inconsistent state‑level AI laws create confusion, ideological inconsistencies, and barriers to national commerce. To counter this, a new federal task force will evaluate and challenge any state AI regulations that clash with the administration’s unified direction.

According to the order, maintaining global AI leadership requires a “minimally burdensome national policy framework.”

What This Means for Insurance Professionals

AI regulation directly shapes how insurance professionals perform their work—particularly those involved in underwriting, claims automation, data modeling, and fraud prevention. Key impacts include:

  • How companies calculate and communicate risk
  • What consumer‑transparency rules must be followed
  • How AI models must be tested, monitored, and audited
  • How innovation is balanced against legal compliance

As new regulations emerge, staying educated is no longer optional—it’s a professional advantage and a compliance necessity.

Related Source & Further Reading

Original coverage from Insurance Journal:
State Insurance Legislators ‘Greatly Disturbed’ by Trump AI Regulation Order

Additional related reporting:
Federal Lawmakers Reject AI Regulation Moratorium
Insurance Industry Rejects Proposed Moratorium on AI Regulation

Stay Ahead of Industry Regulation with Cameron Academy

Professionals across insurance, real estate, mortgage, finance, and medical fields rely on high‑quality education to stay compliant and competitive. Whether you’re expanding your license or launching a new career, Cameron Academy offers state‑approved, real‑world‑focused training built to keep you ahead of regulatory change—AI included.

Visit: CameronAcademy.com

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The Remote Work Revolution: Redefining Real Estate

Imagine a morning where the commute is just a few steps from your bedroom to your home office. This is the reality for many in today's post-pandemic world, where remote work has become a staple of the modern workforce.

By |December 2, 2024|Categories: Article, Real Estate, Remote Work|Tags: , |0 Comments

CRISPR: The Future of Gene Editing and Its Clinical Implications

CRISPR technology has become the frontrunner in genome editing, surpassing earlier methods like zinc finger nucleases and transcription activator-like effector nucleases. The recent FDA approval of the CRISPR-Cas9 drug, exa-cel, marks a significant milestone particularly for treating sickle cell disease and transfusion-dependent beta thalassemia.

By |December 1, 2024|Categories: Article, Biotechnology, Medicine|Tags: , |0 Comments

AI Revolution in Oncology: Transformative Potential or Overhyped?

In recent years, artificial intelligence has emerged as a revolutionary tool in the field of oncology. AI's integration into healthcare transcends buzzwords, transforming cancer diagnosis, treatment personalization, and drug discovery.

AI in Radiology: A Double-Edged Sword

The rapid advancements in artificial intelligence (AI) are transforming the landscape of radiology, promising to enhance diagnostic accuracy and support personalized medicine. However, as this technology becomes more integral to medical imaging, it brings with it a host of ethical and societal considerations that cannot be ignored.

Humanity at the Crossroads: Ethical Implications of AI in Medicine

AI's promise in healthcare is undeniable, with its ability to uncover hidden disease patterns and predict illnesses. However, the reliance on historical data can exacerbate existing biases, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic and racial groups.

The Future of Telemedicine: Challenges and Opportunities Beyond the Pandemic

Telemedicine stands out as a transformative force, offering a lifeline to patients and providers alike. As we move beyond the pandemic, the challenge is to integrate this technology without escalating costs or overshadowing the indispensable role of in-person consultations.

By |November 30, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments